Giulio Pompilio

Acute effects of 17beta-estradiol on left internal mammary graft after coronary artery bypass grafting.

[Autologous cellular cardiomyoplasty in humans: can we hit the mark?].

Six-year monitoring of the donor-specific immune response to cryopreserved aortic allograft valves: implications with valve dysfunction.

Autologous peripheral blood stem cell transplantation for myocardial regeneration: a novel strategy for cell collection and surgical injection.

Invited commentary.

[Clinical studies of cardiac cell therapy in Italy].

Endothelial progenitor cells and cardiovascular homeostasis: clinical implications.

GMP-based CD133(+) cells isolation maintains progenitor angiogenic properties and enhances standardization in cardiovascular cell therapy.

Altered SDF-1-mediated differentiation of bone marrow-derived endothelial progenitor cells in diabetes mellitus.

Determinants of pericardial drainage for cardiac tamponade following cardiac surgery.

Ex vivo acidic preconditioning enhances bone marrow ckit+ cell therapeutic potential via increased CXCR4 expression.

Heart valve engineering: decellularized aortic homograft seeded with human cardiac stromal cells.

MicroRNAs and myocardial infarction.

Patient profile modulates cardiac c-kit(+) progenitor cell availability and amplification potential.

Doxorubicin and trastuzumab regimen induces biventricular failure in mice.

Identification of Kita (c-Kit) positive cells in the heart of adult zebrafish.

The CD133+ cell as advanced medicinal product for myocardial and limb ischemia.

Syngeneic cardiac and bone marrow stromal cells display tissue-specific microRNA signatures and microRNA subsets restricted to diverse differentiation processes.

MicroRNA-34a Induces Vascular Smooth Muscle Cells Senescence by SIRT1 Downregulation and Promotes the Expression of Age-Associated Pro-inflammatory Secretory Factors.

Bone good to the heart: bone marrow cell characteristics and cardiac repair after STEMI in the CCTRN TIME cohort.

c-kit(+) cells: the tell-tale heart of cardiac regeneration?

Peptidyl-prolyl isomerases: a full cast of critical actors in cardiovascular diseases.

Novel Application of 3-Dimensional Real-Time Cardiac Imaging to Guide Stem Cell-Based Therapy.

An International Survey on Taking Up a Career in Cardiovascular Research: Opportunities and Biases toward Would-Be Physician-Scientists.

Acetylation mediates Cx43 reduction caused by electrical stimulation.

Bone Marrow Cell Therapy for Ischemic Heart Disease: The Never Ending Story.

Granulocyte-colony stimulating factor for large anterior ST-elevation myocardial infarction: rationale and design of the prospective randomized phase III STEM-AMI OUTCOME trial.

Higher cardiogenic potential of iPSCs derived from cardiac versus skin stromal cells.

Cyclophilin A modulates bone marrow-derived CD117(+) cells and enhances ischemia-induced angiogenesis via the SDF-1/CXCR4 axis.

Young at Heart: Pioneering Approaches to Model Nonischaemic Cardiomyopathy with Induced Pluripotent Stem Cells.

Vascular smooth muscle cells in Marfan syndrome aneurysm: the broken bricks in the aortic wall.

Endothelial progenitor cells in ageing.

Sildenafil attenuates hypoxic pulmonary remodelling by inhibiting bone marrow progenitor cells.

Cell therapy for heart disease after 15 years: Unmet expectations.

Cell models of arrhythmogenic cardiomyopathy: advances and opportunities.

MiR-320a as a Potential Novel Circulating Biomarker of Arrhythmogenic CardioMyopathy.

Non-oxidizable HMGB1 induces cardiac fibroblasts migration via CXCR4 in a CXCL12-independent manner and worsens tissue remodeling after myocardial infarction.

Arrhythmogenic Cardiomyopathy: the Guilty Party in Adipogenesis.

Derivation of the Duchenne muscular dystrophy patient-derived induced pluripotent stem cell line lacking DMD exons 49 and 50 (CCMi001DMD-A-3, ∆49, ∆50).

Age-dependent increase of oxidative stress regulates microRNA-29 family preserving cardiac health.

Exploring digenic inheritance in arrhythmogenic cardiomyopathy.

Preferential myofibroblast differentiation of cardiac mesenchymal progenitor cells in the presence of atrial fibrillation.

Cell Therapy for Refractory Angina: A Reappraisal.

Generation of induced pluripotent stem cells from a Becker muscular dystrophy patient carrying a deletion of exons 45-55 of the dystrophin gene (CCMi002BMD-A-9 ∆45-55).